Medtech-specific, not medtech-adjacent.

Most patient recruitment firms split their attention across pharma, biotech, and device trials. We don't. Every campaign we run is built around the realities of device trials specifically: shorter enrollment windows, smaller target cohorts, device-specific screening criteria, and usability factors that don't exist in a drug study.

 

Quality creative over volume.

We don't run generic ad templates. Every campaign gets tailored messaging, visuals, and calls-to-action built to resonate with your specific patient population and educate them clearly about the study and the technology. That's what keeps qualification rates high and screen-failure rates low.

 

Partners, not a transaction.

We stay hands-on from kickoff through close-out. When something in the campaign isn't working, you'll hear from us before you have to ask.

 

Real ad-tech experience, applied to clinical context.

Social, programmatic, geo-fencing, and traditional media, deployed with the targeting precision of performance marketing and the judgment of people who understand clinical trial recruitment rules.

 

Fast, clean process.

Discovery call, plan, approvals, launch. No months-long onboarding, no unnecessary friction.

 

IRB-ready creative.

Every ad, landing page, and screening question is built and submitted for your study's IRB approval before anything launches, so compliance isn't a bottleneck, it's built into our process from day one.